Literature DB >> 19438605

Infants with late breast milk acquisition of HIV-1 generate interferon-gamma responses more rapidly than infants with early peripartum acquisition.

B Lohman-Payne1, J A Slyker, B A Richardson, C Farquhar, M Majiwa, E Maleche-Obimbo, D Mbori-Ngacha, J Overbaugh, S Rowland-Jones, G John-Stewart.   

Abstract

Infants infected with HIV-1 after the first month of life have a lower viral set-point and slower disease progression than infants infected before 1 month. We investigated the kinetics of HIV-1-specific CD8(+) T lymphocyte secretion of interferon (IFN)-gamma in infants infected before 1 month of life compared with those infected between months 1 and 12 (late infection). HIV-1 infection was assessed at birth and at months 1, 3, 6, 9 and 12 and timing of infection was determined by HIV-1 gag DNA from dried blood spots and verified by plasma HIV-1 RNA levels. HIV-1 peptide-specific IFN-gamma responses were measured by enzyme-linked immunospot at months 1, 3, 6, 9 and 12. Timing of development of IFN-gamma responses was compared using the log-rank test and Kaplan-Meier survival curves. Infants infected late developed HIV-1-specific CD8(+) T cell responses 2.8 months sooner than infants infected peripartum: 2.3 versus 5.1 months after HIV-1 infection (n = 52, P = 0.04). Late-infected infants had more focused epitope recognition than early-infected infants (median 1 versus 2 peptides, P = 0.03); however, there were no differences in the strength of IFN-gamma responses. In infants infected with HIV-1 after the first month of life, emergence of HIV-1-specific CD8(+) IFN-gamma responses is coincident with the decline in viral load, nearly identical to what is observed in adults and more rapid than in early-infected infants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438605      PMCID: PMC2691981          DOI: 10.1111/j.1365-2249.2009.03937.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples.

Authors:  Dana DeVange Panteleeff; Sandra Emery; Barbra A Richardson; Christine Rousseau; Sarah Benki; Sharon Bodrug; Joan K Kreiss; Julie Overbaugh
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial.

Authors:  D Mbori-Ngacha; R Nduati; G John; M Reilly; B Richardson; A Mwatha; J Ndinya-Achola; J Bwayo; J Kreiss
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

3.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Frequencies of circulating cytolytic, CD45RA+CD27-, CD8+ T lymphocytes depend on infection with CMV.

Authors:  Taco W Kuijpers; Mireille T Vossen; Mi-Ran Gent; Jean-Claude Davin; Marijke T Roos; Pauline M Wertheim-van Dillen; Jan F Weel; Paul A Baars; Rene A van Lier
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

5.  Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.

Authors:  S Emery; S Bodrug; B A Richardson; C Giachetti; M A Bott; D Panteleeff; L L Jagodzinski; N L Michael; R Nduati; J Bwayo; J K Kreiss; J Overbaugh
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination.

Authors:  J Vekemans; M O C Ota; E C Y Wang; M Kidd; L K Borysiewicz; H Whittle; K P W J McAdam; G Morgan; A Marchant
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

7.  Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.

Authors:  Florence Buseyne; Jérôme Le Chenadec; Béatrice Corre; Françoise Porrot; Marianne Burgard; Christine Rouzioux; Stéphane Blanche; Marie-Jeanne Mayaux; Yves Rivière
Journal:  J Infect Dis       Date:  2002-11-01       Impact factor: 5.226

8.  Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk.

Authors:  Carey Farquhar; Thomas C VanCott; Dorothy A Mbori-Ngacha; Lena Horani; Rose K Bosire; Joan K Kreiss; Barbra A Richardson; Grace C John-Stewart
Journal:  J Infect Dis       Date:  2002-09-20       Impact factor: 5.226

9.  Association of Gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus load set point.

Authors:  Deepa S Patke; Susan J Langan; Lucy M Carruth; Sheila M Keating; Beulah P Sabundayo; Joseph B Margolick; Thomas C Quinn; Robert C Bollinger
Journal:  J Infect Dis       Date:  2002-09-30       Impact factor: 5.226

10.  Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants.

Authors:  Christina F Thobakgale; Dhanwanthie Ramduth; Sharon Reddy; Nompumelelo Mkhwanazi; Chantal de Pierres; Eshia Moodley; Wendy Mphatswe; Natasha Blanckenberg; Ayanda Cengimbo; Andrew Prendergast; Gareth Tudor-Williams; Krista Dong; Prakash Jeena; Gupreet Kindra; Raziya Bobat; Hoosen Coovadia; Photini Kiepiela; Bruce D Walker; Philip J R Goulder
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

View more
  6 in total

1.  In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth.

Authors:  B Lohman-Payne; T Sandifer; M OhAinle; C Crudder; J Lynch; M M Omenda; J Maroa; K Fowke; G C John-Stewart; C Farquhar
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.

Authors:  Deborah Persaud; Abubaker Bedri; Carrie Ziemniak; Anitha Moorthy; Berhanu Gudetta; Aida Abashawl; Yohannes Mengistu; Saad B Omer; Abdulhamid Isehak; Solomon Kumbi; Rahel Adamu; Sileshi Lulseged; Roxann Ashworth; Elham Hassen; Andrea Ruff
Journal:  AIDS Res Hum Retroviruses       Date:  2011-02-25       Impact factor: 2.205

Review 3.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

4.  Immune approaches for the prevention of breast milk transmission of HIV-1.

Authors:  Barbara Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection.

Authors:  Jennifer A Slyker; Grace C John-Stewart; Tao Dong; Barbara Lohman-Payne; Marie Reilly; Ann Atzberger; Stephen Taylor; Elizabeth Maleche-Obimbo; Dorothy Mbori-Ngacha; Sarah L Rowland-Jones
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

6.  Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon.

Authors:  Anfumbom K W Kfutwah; Paul Alain T Ngoupo; Casimir Ledoux Sofeu; Francis Ateba Ndongo; Georgette Guemkam; Suzie Tetang Ndiang; Félicité Owona; Ida Calixte Penda; Patrice Tchendjou; Christine Rouzioux; Josiane Warszawski; Albert Faye; Mathurin Cyrille Tejiokem
Journal:  BMC Infect Dis       Date:  2017-03-23       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.